The DOI matches its Crossref record; 19 of the 21 references it cites were found in a registry or an index.
Glucose Transporter 1 Deficiency as a Treatable Cause of Myoclonic Astatic Epilepsy
Open accessAbstract
Objective: To determine if a significant proportion of patients with myoclonic-astatic epilepsy (MAE) have glucose transporter 1 (GLUT1) deficiency. Design: Genetic analysis. Setting: Ambulatory and hospitalized care. Patients: Eighty-four unrelated probands with MAE were phenotyped and SLC2A1 was sequenced and analyzed by multiplex ligation-dependent probe amplification. Any identified mutations were then screened in controls. Main Outcome Measure: Any SLC2A1 mutations. Results: Four of 84 probands with MAE had a mutation of SLC2A1 on sequencing. Multiplex ligation-dependent probe amplification analysis did not reveal any genomic rearrangements in 75 of the remaining cases; 5 could not be tested. Two patients with MAE with SLC2A1 mutations also developed paroxysmal exertional dyskinesia in childhood. Conclusions: Five percent of our patients with MAE had SLC2A1 mutations, suggesting that patients with MAE should be tested for GLUT1 deficiency. Diagnosis of GLUT1 deficiency is a strong indication for early use of the ketogenic diet, which may substantially improve outcome of this severe disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Heterozygous LOF variants in SLC2A1 encoding GLUT1, the major glucose transporter at the blood-brain barrier, cause early onset absence epilepsy, ataxia, epilepsy with myoclonic-atonic seizures, and exercise-induced dyskinesia 93 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vivo, D. C. D., Trifiletti, R. R., Jacobson, R. I., Ronen, G. M., Behmand, R. A., & Harik, S. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251006 · Cited by 796
Ashwal, S., Bale, J. F., Coulter, D. L., Eiben, R., & Garg, B. P. (2006) · Annals of Neurology · doi:10.1002/(issn)1531-8249 · Cited by 514
Weber, Y. G., Storch, A., Wuttke, T. V., Brockmann, K., Kempfle, J. S., Maljevic, S., Margari, L., Kamm, C., Schneider, S. A., Huber, S. M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34438 · Cited by 363
Glut‐1 deficiency syndrome: Clinical, genetic, and therapeutic aspects
Wang, D., Pascual, J. M., Yang, H., Engelstad, K., Jhung, S., Sun, R. P., & Vivo, D. C. D. (2004) · Annals of Neurology · doi:10.1002/ana.20331 · Cited by 331
Early‐onset absence epilepsy caused by mutations in the glucose transporter GLUT1
Suls, A., Mullen, S. A., Weber, Y. G., Verhaert, K., Ceulemans, B., Guerrini, R., Wuttke, T. V., Salvo‐Vargas, A., Deprez, L., Claes, L. R. F., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21724 · Cited by 299
Self-citationTreatment and Long-Term Prognosis of Myoclonic-Astatic Epilepsy of Early Childhood
Oguni, H., Tanaka, T., Hayashi, K., Funatsuka, M., Sakauchi, M., Shirakawa, S., & Osawa, M. (2002) · Neuropediatrics · doi:10.1055/s-2002-33675 · Cited by 199
Autosomal dominant Glut‐1 deficiency syndrome and familial epilepsy
Brockmann, K., Wang, D., Korenke, G. C., von Moers, A., Ho, Y. Y., Pascual, J. M., Kuang, K., Yang, H., Ma, L., Kranz‐Eble, P., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1222 · Cited by 163
Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency
Mullen, S. A., Suls, A., Jonghe, P. D., Berkovic, S. F., & Scheffer, I. E. (2010) · Neurology · doi:10.1212/wnl.0b013e3181eb58b4 · Cited by 160
Self-citationImaging the metabolic footprint of Glut1 deficiency on the brain
Pascual, J. M., Heertum, R. L. V., Wang, D., Engelstad, K., & Vivo, D. C. D. (2002) · Annals of Neurology · doi:10.1002/ana.10311 · Cited by 153
Seizure Characterization and Electroencephalographic Features in Glut‐1 Deficiency Syndrome
Leary, L., Wang, D., Nordli, D. R., Engelstad, K., & Vivo, D. C. D. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.05302.x · Cited by 139
Research works printed but not linked: 1
- Commission on Classification and Terminology of the International League Against Epilepsy, 1989, Proposal for revised classification of epilepsies and epileptic syndromes., Epilepsia, 30, 389, 10.1111/epi.1989.30.issue-4 · DOI
Cited by
Sorted by citations
The genetic landscape of the epileptic encephalopathies of infancy and childhood
McTague, A., Howell, K. B., Cross, J. H., Kurian, M. A., & Scheffer, I. E. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00250-1 · Cited by 609
Self-citationSymonds, J. D., Zuberi, S. M., Stewart, K., McLellan, A., O‘Regan, M., MacLeod, S., Jollands, A., Joss, S., Kirkpatrick, M., Brunklaus, A., et al. (2019) · Brain · doi:10.1093/brain/awz195 · Cited by 459
Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures
Carvill, G. L., McMahon, J. M., Schneider, A., Zemel, M., Myers, C. T., Saykally, J., Nguyen, J., Robbiano, A., Zara, F., Specchio, N., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.02.016 · Cited by 227
Self-citationPhenotypic Spectrum of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Pearson, T. S., Akman, Ç. I., Hinton, V. J., Engelstad, K., & Vivo, D. C. D. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0342-7 · Cited by 226
Glucose Transporters in Brain: In Health and in Alzheimer’s Disease
Szablewski, L. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160841 · Cited by 211
GLUT1 deficiency syndrome 2013: Current state of the art
GIORGIS, V. D., & Veggiotti, P. (2013) · Seizure · doi:10.1016/j.seizure.2013.07.003 · Cited by 178
Precision therapy for epilepsy due to KCNT1 mutations
Mullen, S. A., Carney, P. W., Roten, A., Ching, M., Lightfoot, P. A., Churilov, L. P., Nair, U., Li, M., Berkovic, S. F., Petrou, S., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004769 · Cited by 150
Self-citationThe glucose transporter type 1 (Glut1) syndromes
Koch, H., & Weber, Y. G. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.06.010 · Cited by 144
Glucose transporter 1 deficiency in the idiopathic generalized epilepsies
Arsov, T., Mullen, S. A., Rogers, S., Phillips, A. M., Lawrence, K. M., Damiano, J. A., Goldberg‐Stern, H., Afawi, Z., Kivity, S., Trager, C., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23702 · Cited by 143
Self-citationDevelopmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
Self-citationScheffer, I. E., French, J. A., Hirsch, É., Jain, S., Mathern, G. W., Moshé, S. L., Perucca, E., Tomson, T., Wiebe, S., Zhang, Y., et al. (2016) · Epilepsia Open · doi:10.1002/epi4.5 · Cited by 125
Self-citationMøller, R. S., Wuttke, T. V., Helbig, I., Marini, C., Johannesen, K. M., Brilstra, E. H., Vaher, U., Borggraefe, I., Talvik, I., Talvik, T., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003565 · Cited by 119
Self-citationLarsen, J., Johannesen, K. M., Ek, J., Tang, S. S., Marini, C., Blichfeldt, S., Kibæk, M., von Spiczak, S., Weckhuysen, S., Frangu, M., et al. (2015) · Epilepsia · doi:10.1111/epi.13222 · Cited by 100
Self-citationThe role of genetic testing in epilepsy diagnosis and management
Weber, Y., Biskup, S., Helbig, K., von Spiczak, S., & Lerche, H. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1335598 · Cited by 87
The 2010 Revised Classification of Seizures and Epilepsy
Berg, A. T., & Millichap, J. G. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000431377.44312.9e · Cited by 95
GLUT1 deficiency syndrome: An update
Gras, D., Roze, E. F., Caillet, S., Méneret, A., Doummar, D., de Villemeur, T. B., Vidailhet, M., & Mochel, F. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.09.005 · Cited by 92
Novel mutations and phenotypes of epilepsy‐associated genes in epileptic encephalopathies
Zhou, P., He, N., Zhang, J., Lin, Z., Wang, J., Yan, L. ‐., Meng, H., Tang, B., Li, B., Liu, X., et al. (2018) · Genes Brain & Behavior · doi:10.1111/gbb.12456 · Cited by 88
Is the ketogenic diet effective in specific epilepsy syndromes?
Nangia, S., Caraballo, R. H., Kang, H., Nordli, D. R., & Scheffer, I. E. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.01.015 · Cited by 83
Self-citationErro, R., Bhatia, K. P., Espay, A. J., & Striano, P. (2017) · Movement Disorders · doi:10.1002/mds.26901 · Cited by 80
Precision medicine in genetic epilepsies: break of dawn?
Reif, P. S., Tsai, M., Helbig, I., Rosenow, F., & Klein, K. M. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1253476 · Cited by 77
From splitting GLUT1 deficiency syndromes to overlapping phenotypes
Hully, M., Vuillaumier‐Barrot, S., Bizec, C. L., Boddaert, N., Kamińska, A., Lascelles, K., de Lonlay, P., Cancès, C., Portes, V. D., Roubertie, A., et al. (2015) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2015.06.007 · Cited by 68
Mei, D., Parrini, E., Marini, C., & Guerrini, R. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-017-0257-0 · Cited by 59
Self-citationPhenotypic and genetic spectrum of epilepsy with myoclonic atonic seizures
Tang, S. S., Addis, L., Smith, A. B., Topp, S. D., Pendziwiat, M., Mei, D., Parker, A. P. J., Agrawal, S., Hughes, E., Lascelles, K., et al. (2020) · Epilepsia · doi:10.1111/epi.16508 · Cited by 61
Self-citationThe challenges and innovations for therapy in children with epilepsy
Wilmshurst, J. M., Berg, A. T., Lagae, L. G., Newton, C. R. J. C., & Cross, J. H. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.58 · Cited by 55
NBEA: Developmental disease gene with early generalized epilepsy phenotypes
Mulhern, M., Schrander-Stumpel, C. T. R. M., Stong, N., Brunner, H. G., Bier, L., Lippa, N. C., Riviello, J. J., Rouhl, R. P. W., Kempers, M. J. E., Pfundt, R., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25350 · Cited by 59
From next-generation sequencing to targeted treatment of non-acquired epilepsies
Møller, R. S., Hammer, T. B., Rubboli, G., Lemke, J. R., & Johannesen, K. M. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1573144 · Cited by 53
Nationwide survey of glucose transporter-1 deficiency syndrome (GLUT-1DS) in Japan
Ito, Y., Takahashi, S., Kagitani‐Shimono, K., Natsume, J., Yanagihara, K., Fujii, T., & Oguni, H. (2014) · Brain and Development · doi:10.1016/j.braindev.2014.11.006 · Cited by 51
Ketogenic diet in patients with Lennox–Gastaut syndrome
Caraballo, R. H., Fortini, S., Fresler, S., Armeno, M. L., Agustinho, A., Cresta, A., Mestre, G., & Escobal, N. (2014) · Seizure · doi:10.1016/j.seizure.2014.06.005 · Cited by 51
Personalized medicine in genetic epilepsies – possibilities, challenges, and new frontiers
Helbig, I., & Ellis, C. A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107970 · Cited by 51
Genetic Causes of Generalized Epilepsies
Helbig, I. (2015) · Seminars in Neurology · doi:10.1055/s-0035-1552922 · Cited by 53
Auvin, S. (2012) · Seizure · doi:10.1016/j.seizure.2012.02.005 · Cited by 44
Modified Atkins diet is an effective treatment for children with Doose syndrome
Wiemer‐Kruel, A., Haberlandt, E., Hartmann, H., Wohlrab, G., & Bast, T. (2017) · Epilepsia · doi:10.1111/epi.13701 · Cited by 44
van der Veen, S., Zutt, R., Klein, C., Marras, C., Berkovic, S. F., Caviness, J. N., Shibasaki, H., de Koning, T. J., & Tijssen, M. A. J. (2019) · Movement Disorders · doi:10.1002/mds.27828 · Cited by 43
Self-citationEpilepsy, energy deficiency and new therapeutic approaches including diet
Reid, C. A., Mullen, S. A., Kim, T., & Petrou, S. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.001 · Cited by 42
Self-citationRoutier, L., Verny, F., Barcia, G., Chémaly, N., Desguerre, I., Colleaux, L., & Nabbout, R. (2019) · Clinical Genetics · doi:10.1111/cge.13581 · Cited by 38
Treatment, Therapy and Management of Metabolic Epilepsy: A Systematic Review
Lee, V. L. L., Choo, B. K. M., Chung, Y.-S., Kundap, U. P., Kumari, Y., & Shaikh, M. F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030871 · Cited by 37
Glucose metabolism transporters and epilepsy: Only GLUT 1 has an established role
Hildebrand, M. S., Damiano, J. A., Mullen, S. A., Bellows, S. T., Oliver, K. L., Dahl, H. M., Scheffer, I. E., & Berkovic, S. F. (2014) · Epilepsia · doi:10.1111/epi.12519 · Cited by 37
Self-citationGenetic Testing in Epilepsy: What Should you be Doing?
Scheffer, I. E. (2011) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-11.4.107 · Cited by 35
Self-citationGuerrini, R., Marini, C., & Barba, C. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64142-7.00038-2 · Cited by 35
Self-citationDissecting the genetic basis of myoclonic‐astatic epilepsy
Tang, S. S., & Pal, D. K. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03581.x · Cited by 35
Epilepsy With Myoclonic Atonic Seizures: An Electroclinical Study of 69 Patients
Caraballo, R. H., Chamorro, N., Darra, F., Fortini, S., & Arroyo, H. A. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2012.12.022 · Cited by 35
Wolking, S., Becker, F., Bast, T., Wiemer‐Kruel, A., Mayer, T., Lerche, H., & Weber, Y. G. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7433-5 · Cited by 34
The Pharmacology of New Antiepileptic Drugs
Perucca, E. (2011) · CNS Drugs · doi:10.2165/11587900-000000000-00000 · Cited by 34
Castellotti, B., Ragona, F., Freri, E., Solazzi, R., Ciardullo, S., Tricomi, G., Venerando, A., Salis, B., Canafoglia, L., Villani, F. S., et al. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09280-6 · Cited by 32
Selenium toxicity in sheep grazing reclaimed phosphate mining sites.
Fessler, A. J., Möller, G., Talcott, P. A., & Exon, J. H. (2003) · PubMed · Cited by 32
Evaluation of non‐coding variation in GLUT 1 deficiency
Liu, Y., Lee, J. W. A., Bellows, S. T., Damiano, J. A., Mullen, S. A., Berkovic, S. F., Bahlo, M., Scheffer, I. E., & Hildebrand, M. S. (2016) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.13163 · Cited by 31
Self-citationStriano, P., Auvin, S., Collins, A. R., Horváth, R., Scheffer, I. E., Tzadok, M., Miller, I., Koenig, M. K., Lacy, A., Davis, R., et al. (2022) · Epilepsia · doi:10.1111/epi.17263 · Cited by 29
Self-citationEpileptic Encephalopathies—Clinical Syndromes and Pathophysiological Concepts
von Deimling, M., Helbig, I., & Marsh, E. D. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0720-7 · Cited by 30
Joshi, C., Nickels, K. C., Demarest, S., Eltze, C. M., Cross, J. H., & Wirrell, E. C. (2020) · Seizure · doi:10.1016/j.seizure.2020.11.017 · Cited by 28
Alternative Fuels in Epilepsy and Amyotrophic Lateral Sclerosis
Tefera, T. W., Tan, K. N., McDonald, T. S., & Borges, K. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2106-7 · Cited by 25
Stenger, E., Schaeffer, M., Cancés, C., Motte, J. E., Auvin, S., Ville, D. M., Maurey, H., Nabbout, R., & Martin, A. D. S. (2017) · Epilepsy Research · doi:10.1016/j.eplepsyres.2017.02.005 · Cited by 25
Tan, K. N., Simmons, D. G., Carrasco‐Pozo, C., & Borges, K. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14275 · Cited by 24
Genetic testing in a cohort of patients with potential epilepsy with myoclonic-atonic seizures
Angione, K., Eschbach, K. L., Smith, G. C., Joshi, C., & Demarest, S. (2019) · Epilepsy Research · doi:10.1016/j.eplepsyres.2019.01.008 · Cited by 23
How Can Advances in Epilepsy Genetics Lead to Better Treatments and Cures?
Guerrini, R., & Noebels, J. L. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-8914-1_25 · Cited by 23
Self-citationMyoclonic astatic epilepsy (Doose syndrome) – A lamotrigine responsive epilepsy?
Doege, C., May, T. W., Siniatchkin, M., von Spiczak, S., Stephani, U., & Boor, R. (2012) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2012.10.006 · Cited by 22
Nickels, K. C., Thibert, R. L., Rau, S. M., Demarest, S., Wirrell, E. C., Kossoff, E. H., Joshi, C., Nangia, S., & Shellhaas, R. A. (2018) · Epilepsy Research · doi:10.1016/j.eplepsyres.2018.04.010 · Cited by 22
Oguni, H. (2021) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2021.11.009 · Cited by 20
Genetics of Epilepsy and Relevance to Current Practice
Michelucci, R., Pasini, E., Riguzzi, P., Volpi, L., Dazzo, E., & Nobile, C. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0281-8 · Cited by 20
Brain correlates of spike and wave discharges in GLUT1 deficiency syndrome
Vaudano, A. E., Olivotto, S., Ruggieri, A., Gessaroli, G., GIORGIS, V. D., Parmeggiani, A., Veggiotti, P., & Meletti, S. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.12.026 · Cited by 20
Ketogenic Diet in Epileptic Encephalopathies
Sharma, S., & Tripathi, M. (2013) · Epilepsy Research and Treatment · doi:10.1155/2013/652052 · Cited by 20
Effect of transporter and DNA repair gene polymorphisms to lung cancer chemotherapy toxicity
Chen, J., Wu, L., Wang, Y. X., Yin, J., Li, X., Wang, Z., Li, H., Zou, T., Qian, C., Li, C., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-4048-0 · Cited by 19
New SMARCA2 mutation in a patient with Nicolaides–Baraitser syndrome and myoclonic astatic epilepsy
Tang, S. S., Hughes, E., Lascelles, K., EuroEPINOMICS RES myoclonic astatic epilepsy working group, Simpson, M. A., & Pal, D. K. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37935 · Cited by 19
The role of SLC2A1 in early onset and childhood absence epilepsies
Muhle, H., Helbig, I., Frøslev, T. G., Suls, A., von Spiczak, S., Klitten, L. L., Dahl, H. A., Brusgaard, K., Neubauer, B. A., Jonghe, P. D., et al. (2013) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.11.004 · Cited by 18
Self-citationEpilepsy genetics: The ongoing revolution
Lesca, G., & Depienne, C. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.01.569 · Cited by 19
Wain, K. E., Palen, E., Savatt, J. M., Shuman, D., Finucane, B. M., Seeley, A. H., Challman, T. D., Myers, S. M., & Martin, C. L. (2018) · Human Mutation · doi:10.1002/humu.23607 · Cited by 18
Clinical and genetic characteristics of patients with Doose syndrome
Hinokuma, N., Nakashima, M., Asai, H., Nakamura, K., Akaboshi, S., Fukuoka, M., Togawa, M., Oana, S., Ohno, K., Kasai, M., et al. (2020) · Epilepsia Open · doi:10.1002/epi4.12417 · Cited by 17
Scheffer, I. E. (2012) · Neurology · doi:10.1212/wnl.0b013e318248a245 · Cited by 18
Self-citationDisorders of Glucose Transport
Santer, R., & Klepper, J. (2016) · Springer eBooks · doi:10.1007/978-3-662-49771-5_10 · Cited by 16
New Research With Diets and Epilepsy
Cross, J. H. (2013) · Journal of Child Neurology · doi:10.1177/0883073813487593 · Cited by 15
Glut1 deficiency is a rare but treatable cause of childhood absence epilepsy with atypical features
Insuga, V. M. S., Guerrero, R., Pozo, R. L.-D., Rodrigo-Moreno, M., Martínez‐Cayuelas, E., Giráldez, B. G., Díaz-Gómez, E., Sánchez‐Martín, G., García, L. O., & Serratosa, J. M. (2019) · Epilepsy Research · doi:10.1016/j.eplepsyres.2019.04.003 · Cited by 15
When should clinicians search for GLUT1 deficiency syndrome in childhood generalized epilepsies?
Lebon, S., Suarez, P., Alija, S., Korff, C. M., Fluss, J., Mercati, D., Datta, A., Poloni, C. B., Marcoz, J., Campos‐Xavier, B., et al. (2014) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2014.11.009 · Cited by 15
Treatable Genetic Metabolic Epilepsies
Assi, L., Saklawi, Y., Karam, P. E., & Obeid, M. (2017) · Current Treatment Options in Neurology · doi:10.1007/s11940-017-0467-0 · Cited by 15
Hesse, A., Bevilacqua, J., Shankar, K., & Reddi, H. V. (2018) · Epilepsy Research · doi:10.1016/j.eplepsyres.2018.05.004 · Cited by 15
Occurrence of GLUT1 deficiency syndrome in patients treated with ketogenic diet
Ramm‐Pettersen, A., Nakken, K. O., Haavardsholm, K. C., & Selmer, K. K. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.01.003 · Cited by 14
SCN2A and Its Related Epileptic Phenotypes
Praticò, A. D., Giallongo, A., Arrabito, M., D'Amico, S., Gauci, M. C., Lombardo, G., Polizzi, A., Falsaperla, R., & Ruggieri, M. (2021) · Journal of Pediatric Neurology · doi:10.1055/s-0041-1727097 · Cited by 13
Patel, J., & Mercimek‐Andrews, S. (2016) · The Indian Journal of Pediatrics · doi:10.1007/s12098-015-1979-9 · Cited by 14
Metabolic and degenerative disorders
Granata, T. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52899-5.00045-9 · Cited by 13
Targeted Treatment in Childhood Epilepsy Syndromes
Vezyroglou, A., & Cross, J. H. (2016) · Current Treatment Options in Neurology · doi:10.1007/s11940-016-0407-4 · Cited by 11
Development of a rapid functional assay that predicts GLUT1 disease severity
Zaman, S. M., Mullen, S. A., Petrovski, S., Maljevic, S., Gazina, E. V., Phillips, A. M., Jones, G. D., Hildebrand, M. S., Damiano, J. A., Auvin, S., et al. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000297 · Cited by 11
Self-citationMetabolic Dysfunctions in Epilepsy and Novel Metabolic Treatment Approaches
Tan, K. N., McDonald, T. S., & Borges, K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411462-3.00048-5 · Cited by 11
Glucose transporter type 1 deficiency syndrome: clinical aspects, diagnosis, and treatment
Veneruzzo, G., Loos, M. A., Armeno, M. L., Alonso, C. N., & Caraballo, R. H. (2022) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2022-02677.eng · Cited by 10
Itoh, Y., Oguni, H., Hirano, Y., & Ōsawa, M. (2014) · Brain and Development · doi:10.1016/j.braindev.2014.03.013 · Cited by 9
Familial aggregation of focal seizure semiology in the Epilepsy Phenome/Genome Project
Tobochnik, S. D., Fahlstrom, R., Shain, C., Winawer, M. R., & For the EPGP Investigators (2017) · Neurology · doi:10.1212/wnl.0000000000004052 · Cited by 9
Mastrangelo, M., Manti, F., Ricciardi, G., Cinnante, E. M. C., Cameli, N., Beatrice, A., Tolve, M., & Pisani, F. (2024) · European Journal of Pediatrics · doi:10.1007/s00431-024-05657-6 · Cited by 8
Guerrini, R., Scheffer, I. E., & Balestrini, S. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00032-8 · Cited by 9
Self-citationStructural brain abnormalities in epilepsy with myoclonic atonic seizures
Denervaud, S., Korff, C. M., Fluss, J., Kalser, J., Roulet‐Perez, E., Hagmann, P., & Lebon, S. (2021) · Epilepsy Research · doi:10.1016/j.eplepsyres.2021.106771 · Cited by 7
Evaluation of GLUT1 variation in non-acquired focal epilepsy
Peeraer, A., Damiano, J. A., Bellows, S. T., Scheffer, I. E., Berkovic, S. F., Mullen, S. A., & Hildebrand, M. S. (2017) · Epilepsy Research · doi:10.1016/j.eplepsyres.2017.04.007 · Cited by 7
Self-citationDissecting the phenotypic and genetic spectrum of early childhood-onset generalized epilepsies
Kim, S. Y., Jang, S. S., Kim, J., Kim, H., Hwang, H. Y., Choi, J., Chae, J., Kim, K. J., & Lim, B. C. (2019) · Seizure · doi:10.1016/j.seizure.2019.07.024 · Cited by 7
McTague, A., Scheffer, I. E., Kullmann, D. M., & Sisodiya, S. M. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90820-7.00016-1 · Cited by 6
Self-citationMyoclonic occipital photosensitive epilepsy with dystonia (MOPED): A familial epilepsy syndrome
Sadleir, L. G., Paterson, S. J., Smith, K. R., Redshaw, N., Ranta, A. A., Kalnins, R. M., Berkovic, S. F., Bahlo, M., Hildebrand, M. S., & Scheffer, I. E. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.04.014 · Cited by 6
Self-citationGenetics in clinical epilepsy: Issues in genetic testing and counseling
Poduri, A., & Sheidley, B. R. (2015) · Journal of Pediatric Epilepsy · doi:10.3233/pep-2012-023 · Cited by 6
Caraballo, R. H., Valenzuela, G. R., Fortini, S., Espeche, A., Gamboni, B., Bautista, C., Cachia, P., Semprino, M., Gallo, A., & Galicchio, S. (2022) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.108702 · Cited by 6
Clinical and genetic landscape of epilepsies with absence seizures and single‐gene etiology
Balestrini, S., Galli, I. C., Ricci, M. L., Parrini, E., Mei, D., Mastrangelo, M., Pisani, F., Filippi, C., Giordano, L., Cesaroni, E., et al. (2025) · Epilepsia · doi:10.1111/epi.18655 · Cited by 6
Self-citationProgress of ketogenic diet in the treatment of developmental epileptic encephalopathy
Hu, W., Li, X., Zhao, F. Q., Zhang, H., & Zhang, H. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1567095 · Cited by 4
Ferraro, T. N. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.888651 · Cited by 4
Understanding the Spectrum of SLC2A1-Associated Disorders
Fajardo, M., & Cirillo, M. L. (2017) · Pediatric Neurology Briefs · doi:10.15844/pedneurbriefs-31-2-1 · Cited by 4
Coorg, R. K., Weisenberg, J. L. Z., & Wong, M. L. (2013) · Neurologic Clinics · doi:10.1016/j.ncl.2013.04.003 · Cited by 4
Ketogenic Diet in Established Epilepsy Indications
Bergin, A. M. R. (2016) · doi:10.1093/med/9780190497996.003.0006 · Cited by 4
Nott, E., Behl, K. E., Brambilla, I., Green, T. E., Lucente, M., Vavassori, R., Watson, A., Bernardina, B. D., & Hildebrand, M. S. (2023) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2022.104680 · Cited by 3
Häufige Epilepsieformen im Kindes- und Erwachsenenalter
Wolking, S., & Lerche, H. (2014) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-014-0791-9 · Cited by 3
Metadata
- Authors
- Mullen, S. A., Marini, C., Suls, A., Mei, D., Della Giustina, E., Buti, D., Arsov, T., Damiano, J., Lawrence, K., De Jonghe, P., Berkovic, S. F., Scheffer, I. E., & Guerrini, R.
- Affiliations
- The University of Melbourne (AU)
- Royal Children's Hospital (AU)
- Corresponding author
- Guerrini, Renzo
- ORCID
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2011-09-01
- Volume
- 68
- Issue
- 9
- Pages
- 1152
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2133660627
- Cited by
- 138
- References
- 21
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 7 · 2021: 6 · 2020: 7 · 2019: 10 · 2018: 11 · 2017: 15 · 2016: 12 · 2015: 12 · 2014: 18 · 2013: 10 · 2012: 11
- FWCI
- 9.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Zenodo (CERN European Organization for Nuclear Research) (other-oa)
- Funders
- American Epilepsy Society
- Jack Brockhoff Foundation
- Danish Cancer Society Research Center
- European Commission
- University of Melbourne
- Vlaamse regering
- Epilepsy Society
- Shepherd Foundation
- Medical Research Council
- National Health and Medical Research Council
- Health Research Council of New Zealand
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- myoclonic-astatic epilepsy, GLUT1 deficiency syndrome, glucose transporter 1, ketogenic diet, genetic diagnosis
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Epilepsies, Myoclonic, Humans, Male, Mutation, Severity of Illness Index, Cohort Studies, Treatment Outcome, Glucose Transporter Type 1, Diet, Ketogenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
